Given our previous data showing that patients with COPD treated with ICSs have reduced basal airway expression of IFNβ,8 we hypothesized that downregulation of ACE2 by FP may be functionally related to its suppressive effects on type I interferon signaling. Here, ACE2 is linked to chronic obstructive pulmonary disease.